Millipore Sigma Vibrant Logo

121765 AG 825 - CAS 149092-50-2 - Calbiochem

概述

Replacement Information

重要规格表

CAS #Empirical Formula
149092-50-2C₁₉H₁₅N₃O₃S₂

价格及供货情况

产品目录编号 库存情况包装 数量 / 包装 价格 数量
121765-2MGCN
正在查询供货情况......
目前缺货
目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余:另行通知
      其余:另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      塑胶安瓿;塑胶针药瓶 2 mg
      正在检索价格......
      无法检索价格。
      最小订购数量为倍数
      Maximum Quantity is
      以订单确认为准 更多信息
      您节约了 ()。
       
      Request Pricing
      Description
      OverviewA potent, cell-premeable, reversible, substrate competitive, and selective inhibitor of HER2 (neu/ErbB2; IC50 = 0.35 µM) relative to HER1 (IC50 = 19 µM) autophosphorylation. The inhibition is competitive with respect to ATP binding. Enhances chemosensitivity in non-small cell lung cancer (NSCLC) cell lines expressing high levels of p185neu.
      Catalogue Number121765
      Brand Family Calbiochem®
      Synonyms4-Hydroxy-3-methoxy-5-(benzothiazolylthiomethyl)benzylidenecyanoacetamide
      References
      ReferencesAshton, J.M., et al. 2012. Cell Stem Cell 11, 359.
      Tsai, C.M., et al. 1996. Cancer Res. 56, 1068.
      Levitzki, A., and Gazit, A. 1995. Science 267, 1782.
      Osherov, N., et al. 1993. J. Biol. Chem. 268, 11134.
      Product Information
      CAS number149092-50-2
      ATP CompetitiveN
      FormYellow solid
      Hill FormulaC₁₉H₁₅N₃O₃S₂
      Chemical formulaC₁₉H₁₅N₃O₃S₂
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetHER2
      Primary Target IC<sub>50</sub>0.35 µM against HER2
      Purity≥94% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2-3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      121765-2MGCN 07790788047917

      Documentation

      AG 825 - CAS 149092-50-2 - Calbiochem 分析证书

      标题批号
      121765

      参考

      参考信息概述
      Ashton, J.M., et al. 2012. Cell Stem Cell 11, 359.
      Tsai, C.M., et al. 1996. Cancer Res. 56, 1068.
      Levitzki, A., and Gazit, A. 1995. Science 267, 1782.
      Osherov, N., et al. 1993. J. Biol. Chem. 268, 11134.
      数据表

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision24-March-2015 JSW
      Synonyms4-Hydroxy-3-methoxy-5-(benzothiazolylthiomethyl)benzylidenecyanoacetamide
      DescriptionA potent, cell-premeable, reversible, substrate competitive, and selective inhibitor of HER-2 (neu/erbB-2, IC50 = 0.35 µM) relative to HER-1 (IC50 = 19 µM) autophosphorylation. The inhibition is competitive with respect to ATP binding. Enhances the chemosensitivity in non-small cell lung cancer (NSCLC) cell lines expressing high levels of p185neu.
      FormYellow solid
      CAS number149092-50-2
      Chemical formulaC₁₉H₁₅N₃O₃S₂
      Structure formulaStructure formula
      Purity≥94% by HPLC
      SolubilityDMSO (10 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2-3 months at -20°C.
      Toxicity Standard Handling
      ReferencesAshton, J.M., et al. 2012. Cell Stem Cell 11, 359.
      Tsai, C.M., et al. 1996. Cancer Res. 56, 1068.
      Levitzki, A., and Gazit, A. 1995. Science 267, 1782.
      Osherov, N., et al. 1993. J. Biol. Chem. 268, 11134.